Immunopathogenesis and therapy of cutaneous T cell lymphoma
Top Cited Papers
- 1 April 2005
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 115 (4) , 798-812
- https://doi.org/10.1172/jci24826
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responsesAntiviral Research, 2004
- IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T CellsThe Journal of Immunology, 2003
- p16INK4a Is Selectively Silenced in the Tumoral Progression of Mycosis FungoidesLaboratory Investigation, 2002
- Cutaneous T Cell LymphomaAnnals of the New York Academy of Sciences, 2001
- Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.American Journal of Public Health, 1999
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined populationJournal of the American Academy of Dermatology, 1990
- Leu-8/CD7 antigen expression by CD3+ T cells: Comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood valuesJournal of the American Academy of Dermatology, 1990
- An unusual and fatal case of disseminated cutaneous herpes simplexJournal of the American Academy of Dermatology, 1981
- Serum IgE in mycosis fungoides.BMJ, 1978